What are the characteristics of inhalation anesthetic agents, including minimum alveolar concentration (MAC), blood‑gas (B/G) and oil‑gas (O/G) solubility coefficients, the concentration effect, the second‑gas effect, and their clinical uses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Inhalation Anesthetic Agents: Characteristics and Clinical Applications

Minimum Alveolar Concentration (MAC)

MAC represents the alveolar concentration of an inhaled anesthetic at which 50% of patients do not move in response to surgical incision, serving as the standard measure of anesthetic potency. 1, 2

  • Sevoflurane MAC in oxygen for a 40-year-old adult is 2.1%, decreasing with age 1
  • Isoflurane MAC values vary by age and carrier gas: 1.28% in 100% oxygen for 26-year-olds, 1.15% for 44-year-olds, and 1.05% for 64-year-olds; when combined with 70% N₂O, these values decrease to 0.56%, 0.50%, and 0.37% respectively 2
  • MAC provides a framework for three clinical endpoints: MACawake (loss of response to verbal command), MAC (immobility), and MACBAR (autonomic reflex control), allowing precise determination of anesthetic depth 3
  • Opioids differentially affect these MAC endpoints, reducing the required concentration of inhaled agents 3

Blood-Gas Partition Coefficient (B/G)

The blood-gas partition coefficient determines the speed of anesthetic induction and emergence—lower values produce faster onset and recovery. 1, 4

  • Sevoflurane has a blood/gas partition coefficient of 0.63-0.69 at 37°C, enabling rapid equilibration between alveolar and arterial partial pressures 1
  • Isoflurane demonstrates minimal biotransformation with only 0.2% metabolism, reflecting its low blood solubility 2, 4
  • Desflurane (I-653) has the lowest blood/gas coefficient at 0.424, predicting the most rapid induction and recovery among modern agents 5
  • The low blood solubility means minimal anesthetic needs to dissolve in blood before alveolar-arterial equilibrium occurs, explaining the rapid FA/FI ratio increase during induction 1

Clinical Implications of B/G Coefficients

  • Time to reach 50% of inspired concentration (FA/FI = 0.5) is approximately 1 minute for sevoflurane versus 4-8 minutes for isoflurane, demonstrating sevoflurane's faster uptake 1
  • Sevoflurane uptake is faster than isoflurane and halothane but slower than desflurane when normalized data are compared 1
  • Blood/gas partition coefficients of modern agents may be less clinically important than traditionally assumed, as all contemporary agents provide adequately rapid control 3

Oil-Gas Partition Coefficient (O/G)

The oil-gas partition coefficient correlates inversely with anesthetic potency—higher oil solubility predicts lower MAC values. 5, 6

  • Desflurane has an oil/gas partition coefficient of 18.7, indicating it requires a MAC four to five times that of isoflurane for equivalent anesthetic effect 5
  • This relationship explains why agents with higher lipid solubility accumulate more readily in the central nervous system, producing anesthesia at lower alveolar concentrations 6
  • The oil-gas coefficient helps predict adequate potency for clinical use—agents must achieve sufficient lipid solubility to produce anesthesia at safe, deliverable concentrations 6

Concentration Effect

The concentration effect describes the phenomenon whereby higher inspired concentrations of an anesthetic produce disproportionately faster increases in alveolar concentration beyond simple mass action. 3

  • This occurs because high-volume uptake of anesthetic from alveoli creates a concentrating effect on remaining alveolar gas, accelerating the rise in FA/FI 3
  • The concentration effect is most clinically relevant during induction with high initial concentrations of volatile agents 3
  • Understanding this effect requires moving beyond Riley's simplistic model to account for ventilation-perfusion relationships that influence gas uptake 3

Second Gas Effect

The second gas effect occurs when high-volume uptake of one gas (typically nitrous oxide) accelerates the alveolar rise of a concurrently administered volatile anesthetic. 7, 3

  • Recent clinical studies demonstrate the second gas effect is considerably greater on arterial blood partial pressures than on end-expired partial pressures, with mathematical modeling confirming this finding 7
  • A significant second gas effect on blood partial pressures occurs even at relatively low rates of nitrous oxide uptake, contrary to older assumptions 7
  • The magnitude is greatest for the least soluble volatile agent (desflurane) and least for the most soluble (diethyl ether) in blood, while opposite results apply in the gas phase 7

Clinical Significance of Second Gas Effect

  • Gas-based MAC readings may underestimate the depth of anesthesia during nitrous oxide co-administration with volatile agents, particularly for less soluble agents like sevoflurane and desflurane 7
  • Increasing ventilation-perfusion mismatch increases the second gas effect in blood while simultaneously decreasing it in the gas phase 7
  • This effect explains why 70% N₂O reduces the required MAC of isoflurane by approximately 50% (from 1.15% to 0.50% in 44-year-olds) 2

Clinical Uses and Agent Selection

Sevoflurane

Sevoflurane is the preferred inhalational anesthetic over desflurane or isoflurane when clinical benefits are equal, according to the French Society of Anesthesia and Resuscitation. 8, 9

  • Rapid, pleasant induction makes sevoflurane suitable for pediatric anesthesia, though halothane historically held this role 4
  • Sevoflurane undergoes 4-5% metabolism, producing inorganic fluoride but at levels generally below nephrotoxic thresholds 9, 4
  • Both sevoflurane and isoflurane provide cardioprotection in ischemia-reperfusion settings, making them appropriate for coronary revascularization 10
  • Sevoflurane does not irritate the respiratory tract, making it particularly valuable during tracheal surgery or direct airway manipulation 10

Isoflurane

Isoflurane maintains stable cardiac rhythm and myocardial contractility better than halothane, though airway irritability limits induction speed despite low blood-gas solubility. 2, 4

  • Isoflurane is the agent of choice for neurosurgical operations due to favorable cerebrovascular effects 4
  • Isoflurane undergoes minimal biotransformation with only 0.2% metabolism, virtually eliminating concerns about toxic metabolites 2, 4
  • All commonly used muscle relaxants are markedly potentiated with isoflurane, with the most profound effect on nondepolarizing agents requiring dose reduction 2
  • Isoflurane can produce coronary vasodilation and theoretical "coronary steal," though clinical studies have not established increased myocardial ischemia risk in coronary artery disease patients 2

Nitrous Oxide Considerations

The French Society of Anesthesia and Resuscitation strongly recommends not utilizing nitrous oxide when choosing an inhalational anesthetic due to environmental concerns. 8, 11

  • Nitrous oxide potency is insufficient to produce anesthesia by itself, requiring combination with other agents 6
  • Despite environmental concerns, nitrous oxide remains clinically useful for its analgesic properties and MAC-reducing effects 3
  • When nitrous oxide is used, delivery via bottle rather than canister and delivery circuit reduces environmental impact 8

Environmental and Sustainability Considerations

Current anesthetic practice should focus on patient needs and established best practices, as scarce lifecycle assessment evidence does not allow definitive conclusions regarding overall environmental impacts. 8, 10

  • When administered without nitrous oxide at 0.5 L/min fresh gas flow using modern manufacturing, sevoflurane generates approximately 0.996 kg CO₂ per MAC-hour, comparable to propofol TIVA at 1.013 kg CO₂ per MAC-hour 10
  • Anesthesia professionals should use low fresh gas flow techniques to reduce environmental impact while maintaining patient safety 8, 11
  • Monitoring depth of anesthesia with end-tidal anesthetic concentration helps reduce consumption of anesthetic vapors 8, 11
  • Existing lifecycle assessments are incomplete, failing to evaluate non-greenhouse gas impacts such as propofol water toxicity and plastic waste from infusion sets 8

Common Pitfalls

  • Avoid relying solely on end-tidal concentrations during nitrous oxide co-administration, as the second gas effect causes gas-based MAC readings to underestimate actual anesthetic depth in blood 7
  • Do not assume blood-gas coefficients alone determine clinical utility—airway irritability (isoflurane) and other factors influence practical induction speed 2, 3
  • Recognize that environmental considerations should not override patient-centered outcomes until more comprehensive lifecycle data become available 8, 10

References

Research

Characteristics of anesthetic agents used for induction and maintenance of general anesthesia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pharmacodynamic Differences Between Sevoflurane and Isoflurane

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anesthesia Management in Surgical Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Environmental Considerations in Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.